Iovance Biotherapeutics: The High?Risk Cancer Stock I Think Could Change a Portfolio by 2036

2026-03-05 17:47:00 ET

Penny stocks sometimes offer significant upside potential. However, they also carry far more risk than more established corporations. Before investing in a penny stock, investors must do their due diligence (as usual) and ensure they are comfortable with the heightened risk and volatility.

Let's consider one penny stock that looks very risky but, given near-perfect execution, could see its shares skyrocket over the next decade: Iovance Biotherapeutics (NASDAQ: IOVA) . Here is more on this cancer-fighting company.

Image source: Getty Images.

Continue reading